Annual CFO
-$14.26 M
-$4.29 M-42.97%
December 31, 2023
Summary
- As of February 8, 2025, ALIM annual cash flow from operations is -$14.26 million, with the most recent change of -$4.29 million (-42.97%) on December 31, 2023.
- During the last 3 years, ALIM annual CFO has fallen by -$12.07 million (-550.30%).
Performance
ALIM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
$1.03 M
+$1.59 M+281.27%
June 30, 2024
Summary
- As of February 8, 2025, ALIM quarterly cash flow from operations is $1.03 million, with the most recent change of +$1.59 million (+281.27%) on June 30, 2024.
- Over the past year, ALIM quarterly CFO has increased by +$10.85 million (+110.44%).
Performance
ALIM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$5.60 M
+$7.02 M+55.65%
June 30, 2024
Summary
- As of February 8, 2025, ALIM TTM cash flow from operations is -$5.60 million, with the most recent change of +$7.02 million (+55.65%) on June 30, 2024.
- Over the past year, ALIM TTM CFO has increased by +$12.69 million (+69.39%).
Performance
ALIM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ALIM Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -43.0% | +110.4% | +69.4% |
| 3 y3 years | -550.3% | -84.7% | -414.4% |
| 5 y5 years | -23.4% | +126.3% | -34.8% |
ALIM Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +342.3% | at low | -72.8% | -1057.7% | +73.6% | +226.7% |
| 5 y | 5-year | +550.3% | at low | -84.7% | -1057.7% | -414.4% | +226.7% |
| alltime | all time | +550.3% | +218.1% | -84.7% | -1659.6% | -414.4% | +715.3% |
Alimera Sciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | $1.03 M(-281.3%) | -$5.60 M(-55.7%) |
| Mar 2024 | - | -$566.00 K(-115.0%) | -$12.62 M(-11.5%) |
| Dec 2023 | -$14.26 M(+43.0%) | $3.77 M(-138.4%) | -$14.26 M(-22.0%) |
| Sep 2023 | - | -$9.83 M(+63.9%) | -$18.28 M(+76.3%) |
| Jun 2023 | - | -$6.00 M(+171.4%) | -$10.37 M(+73.7%) |
| Mar 2023 | - | -$2.21 M(+780.1%) | -$5.97 M(-40.1%) |
| Dec 2022 | -$9.97 M(+209.4%) | -$251.00 K(-86.9%) | -$9.97 M(-30.8%) |
| Sep 2022 | - | -$1.91 M(+19.7%) | -$14.41 M(-5.4%) |
| Jun 2022 | - | -$1.60 M(-74.3%) | -$15.23 M(+119.5%) |
| Mar 2022 | - | -$6.21 M(+32.7%) | -$6.94 M(+115.1%) |
| Dec 2021 | -$3.22 M(+47.0%) | -$4.68 M(+71.4%) | -$3.22 M(-369.6%) |
| Sep 2021 | - | -$2.73 M(-140.8%) | $1.20 M(-32.8%) |
| Jun 2021 | - | $6.69 M(-367.6%) | $1.78 M(-134.0%) |
| Mar 2021 | - | -$2.50 M(+851.0%) | -$5.24 M(+139.0%) |
| Dec 2020 | -$2.19 M(-47.2%) | -$263.00 K(-87.8%) | -$2.19 M(+45.4%) |
| Sep 2020 | - | -$2.15 M(+550.9%) | -$1.51 M(-53.7%) |
| Jun 2020 | - | -$330.00 K(-160.2%) | -$3.26 M(-16.2%) |
| Mar 2020 | - | $548.00 K(+29.9%) | -$3.89 M(-6.4%) |
| Dec 2019 | -$4.15 M(-64.1%) | $422.00 K(-110.8%) | -$4.15 M(+6.1%) |
| Sep 2019 | - | -$3.90 M(+306.0%) | -$3.91 M(+2.3%) |
| Jun 2019 | - | -$960.00 K(-438.0%) | -$3.83 M(-38.5%) |
| Mar 2019 | - | $284.00 K(-57.0%) | -$6.22 M(-46.2%) |
| Dec 2018 | -$11.55 M(-10.3%) | $660.00 K(-117.3%) | -$11.55 M(-17.0%) |
| Sep 2018 | - | -$3.81 M(+13.6%) | -$13.92 M(-2.5%) |
| Jun 2018 | - | -$3.35 M(-33.6%) | -$14.28 M(+3.9%) |
| Mar 2018 | - | -$5.05 M(+195.7%) | -$13.75 M(+6.8%) |
| Dec 2017 | -$12.87 M(-48.7%) | -$1.71 M(-59.1%) | -$12.87 M(-5.1%) |
| Sep 2017 | - | -$4.17 M(+47.8%) | -$13.57 M(-24.2%) |
| Jun 2017 | - | -$2.82 M(-32.3%) | -$17.90 M(-20.6%) |
| Mar 2017 | - | -$4.17 M(+73.5%) | -$22.53 M(-10.2%) |
| Dec 2016 | -$25.10 M(-44.7%) | -$2.40 M(-71.7%) | -$25.10 M(-20.5%) |
| Sep 2016 | - | -$8.50 M(+13.9%) | -$31.59 M(-1.0%) |
| Jun 2016 | - | -$7.46 M(+10.8%) | -$31.91 M(-14.7%) |
| Mar 2016 | - | -$6.74 M(-24.3%) | -$37.40 M(-17.6%) |
| Dec 2015 | -$45.36 M | -$8.89 M(+0.8%) | -$45.36 M(-0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | -$8.82 M(-31.9%) | -$45.62 M(+9.3%) |
| Jun 2015 | - | -$12.95 M(-11.9%) | -$41.76 M(+27.4%) |
| Mar 2015 | - | -$14.70 M(+60.7%) | -$32.78 M(+34.9%) |
| Dec 2014 | -$24.30 M(-35.7%) | -$9.15 M(+84.7%) | -$24.30 M(-2.3%) |
| Sep 2014 | - | -$4.95 M(+24.4%) | -$24.88 M(-14.0%) |
| Jun 2014 | - | -$3.98 M(-36.0%) | -$28.92 M(-15.6%) |
| Mar 2014 | - | -$6.22 M(-36.1%) | -$34.26 M(-9.4%) |
| Dec 2013 | -$37.82 M(+78.6%) | -$9.73 M(+8.1%) | -$37.82 M(+8.7%) |
| Sep 2013 | - | -$8.99 M(-3.5%) | -$34.78 M(+15.1%) |
| Jun 2013 | - | -$9.32 M(-4.6%) | -$30.22 M(+18.3%) |
| Mar 2013 | - | -$9.78 M(+46.2%) | -$25.55 M(+20.6%) |
| Dec 2012 | -$21.18 M(+2.2%) | -$6.69 M(+50.8%) | -$21.18 M(+11.1%) |
| Sep 2012 | - | -$4.43 M(-4.7%) | -$19.06 M(-5.6%) |
| Jun 2012 | - | -$4.65 M(-14.1%) | -$20.20 M(-4.4%) |
| Mar 2012 | - | -$5.41 M(+18.5%) | -$21.14 M(+2.0%) |
| Dec 2011 | -$20.72 M(-6.1%) | -$4.57 M(-18.0%) | -$20.72 M(-6.6%) |
| Sep 2011 | - | -$5.57 M(-0.3%) | -$22.18 M(+1.5%) |
| Jun 2011 | - | -$5.59 M(+11.9%) | -$21.84 M(-2.5%) |
| Mar 2011 | - | -$4.99 M(-17.2%) | -$22.40 M(+1.6%) |
| Dec 2010 | -$22.05 M(+25.7%) | -$6.03 M(+15.0%) | -$22.05 M(+6.3%) |
| Sep 2010 | - | -$5.24 M(-14.7%) | -$20.75 M(+6.9%) |
| Jun 2010 | - | -$6.14 M(+32.5%) | -$19.42 M(+4.1%) |
| Mar 2010 | - | -$4.64 M(-1.8%) | -$18.65 M(+6.3%) |
| Dec 2009 | -$17.54 M(-45.4%) | -$4.73 M(+20.9%) | -$17.54 M(-18.1%) |
| Sep 2009 | - | -$3.91 M(-27.3%) | -$21.40 M(-0.8%) |
| Jun 2009 | - | -$5.37 M(+52.2%) | -$21.57 M(+9.8%) |
| Mar 2009 | - | -$3.53 M(-58.9%) | -$19.64 M(-38.8%) |
| Dec 2008 | -$32.12 M(+148.2%) | -$8.59 M(+110.7%) | -$32.12 M(+36.5%) |
| Sep 2008 | - | -$4.08 M(+18.3%) | -$23.52 M(+21.0%) |
| Jun 2008 | - | -$3.45 M(-78.5%) | -$19.45 M(+8.3%) |
| Mar 2008 | - | -$16.00 M(+721.4%) | -$17.95 M(+169.3%) |
| Dec 2007 | -$12.94 M(-37.8%) | - | - |
| Jun 2007 | - | -$1.95 M(-58.7%) | -$6.66 M(+41.3%) |
| Mar 2007 | - | -$4.72 M | -$4.72 M |
| Dec 2006 | -$20.78 M | - | - |
FAQ
- What is Alimera Sciences annual cash flow from operations?
- What is the all time high annual CFO for Alimera Sciences?
- What is Alimera Sciences annual CFO year-on-year change?
- What is Alimera Sciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Alimera Sciences?
- What is Alimera Sciences quarterly CFO year-on-year change?
- What is Alimera Sciences TTM cash flow from operations?
- What is the all time high TTM CFO for Alimera Sciences?
- What is Alimera Sciences TTM CFO year-on-year change?
What is Alimera Sciences annual cash flow from operations?
The current annual CFO of ALIM is -$14.26 M
What is the all time high annual CFO for Alimera Sciences?
Alimera Sciences all-time high annual cash flow from operations is -$2.19 M
What is Alimera Sciences annual CFO year-on-year change?
Over the past year, ALIM annual cash flow from operations has changed by -$4.29 M (-42.97%)
What is Alimera Sciences quarterly cash flow from operations?
The current quarterly CFO of ALIM is $1.03 M
What is the all time high quarterly CFO for Alimera Sciences?
Alimera Sciences all-time high quarterly cash flow from operations is $6.69 M
What is Alimera Sciences quarterly CFO year-on-year change?
Over the past year, ALIM quarterly cash flow from operations has changed by +$10.85 M (+110.44%)
What is Alimera Sciences TTM cash flow from operations?
The current TTM CFO of ALIM is -$5.60 M
What is the all time high TTM CFO for Alimera Sciences?
Alimera Sciences all-time high TTM cash flow from operations is $1.78 M
What is Alimera Sciences TTM CFO year-on-year change?
Over the past year, ALIM TTM cash flow from operations has changed by +$12.69 M (+69.39%)